Cargando…
Impact of COVID-19 vaccination on the use of PD-1 inhibitor in treating patients with cancer: a real-world study
Anti-COVID-19 vaccination may have functional implications for immune checkpoint inhibitor treatment in patients with cancer. This study was undertaken to determine whether the safety or efficacy of anti-PD-1 therapy is reduced in patients with cancer during COVID-19 vaccination. A large multicenter...
Autores principales: | Mei, Qi, Hu, Guangyuan, Yang, Yang, Liu, Bo, Yin, Junping, Li, Ming, Huang, Qiao, Tang, Xi, Böhner, Alexander, Bryant, Amy, Kurts, Christian, Yuan, Xianglin, Li, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915379/ https://www.ncbi.nlm.nih.gov/pubmed/35264438 http://dx.doi.org/10.1136/jitc-2021-004157 |
Ejemplares similares
-
Health Issues and Immunological Assessment Related to Wuhan's COVID-19 Survivors: A Multicenter Follow-Up Study
por: Mei, Qi, et al.
Publicado: (2021) -
Informing real-world practice with real-world evidence: the value of PRECIS-2
por: Neta, Gila, et al.
Publicado: (2018) -
Trends in clinical development of pediatric cancer for PD-1 and PD-L1 inhibitors: an analysis of ClinicalTrials.gov
por: Que, Yi, et al.
Publicado: (2021) -
The Hierarchy of Antigen Delivery
por: Garbi, Natalio, et al.
Publicado: (2016) -
Survival Factors and Metabolic Pathogenesis in Elderly Patients (≥65) With COVID-19: A Multi-Center Study
por: Mei, Qi, et al.
Publicado: (2021)